The SingHealth Duke-NUS Academic Medical Centre (AMC) has launched the Artificial Intelligence in Medicine Institute (AIMI), announced at the opening ceremony of the AI Health World Summit 2025 held earlier this month.
AIMI is intended to bring together SingHealth’s data science and AI capabilities and Duke-NUS’ academic network to drive research, education and commercialisation.
An increasingly integral and transformative force in healthcare, AI capabilities aid the diagnosis of diseases, guide clinical treatments, and enhance patient experience.
As AI continues to gain widespread use and acceptance, it has become essential to create an environment with the resources that supports healthcare professionals in integrating AI into their work.
AIMI is intended to equip healthcare professionals across medical specialties with the expertise and support they need to create, develop and apply AI-driven solutions.
The Institute’s goal is to bridge the gap between technical expertise and clinical knowledge by fostering an environment that promotes meaningful partnerships with local and global experts in the field, and providing resources and grants to turn innovative ideas into reality.
To equip healthcare professionals and the public with AI knowledge, AIMI will introduce AI101, a flagship online training series offering foundational insights into AI’s unique considerations and applications in healthcare.
While the use of AI has tremendous potential in unlocking benefits for patients and healthcare professionals, it is critical to ensure ethical, responsible and trustworthy applications.
Through the development of guidelines, publications and policy recommendations, AIMI aims to promote a strong and robust governance framework as efforts to encourage adoption of AI increase.
Liu Nan, director of the Duke-NUS AI + Medical Sciences Initiative (DAISI) and co-director of AIMI, said that AI has the power to revolutionise healthcare, but its adoption must be responsible and patient-centred.
“AIMI brings together expertise from healthcare, engineering and data science to transform data into vital intelligence that can be used to make critical care decisions faster at the patients’ bedside,” said Liu.
“Beyond technology, we aim to cultivate future leaders who will drive AI advancements through strategic collaborations and education,” he said.
Daniel Ting, director of the AI Office at SingHealth and co-director of AIMI, said that as AI becomes more widely used in healthcare, it is crucial for the tech industry and regulatory bodies to collaborate closely and proactively develop comprehensive guidelines to ensure that AI-driven solutions are compliant and in accordance with stringent safety guidelines and governance frameworks.
“Our ultimate aim is to create transparent, explainable, and ethical AI systems that empower clinicians to deliver precise and personalised care to every patient, to achieve greater efficiency and positive outcomes in healthcare delivery,” said Ting.
